Related Experiment Video
Updated: Jul 8, 2026

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model
Published on: November 29, 2024
Pathogenesis and treatment of type 2 diabetic nephropathy: lessons from the spontaneous KK/Ta mouse model
Yasuhiko Tomino1, Mitsuo Tanimoto, Toshihide Shike
1Division of Nephrology, Department of Internal Medicine, Juntendo University School of Medicine, Tokyo, Japan. yasu@med.juntendo.ac.jp
Abstract:
Diabetic nephropathy is a major cause of end-stage renal failure (ESRF) in patients with both type 1 and type 2 diabetes. Many factors such as genetic and non-genetic promoters, hypertension, hyperglycemia, accumulation of advanced glycation end products (AGEs), dyslipidemia, albuminuria and proteinuria influence the progression of this disease. It is important to determine pathogenesis and treatment of this disease. However, it is difficult to investigate since human diabetes is a heterogeneous and multifactorial disease. Therefore, most of these mechanisms have been investigated in animal experiments. KK/Ta mice have a clearly different genetic background in terms of body weight, blood glucose, impaired glucose tolerance (IGT), urinary albumin excretion and serum triglyceride than BALB/c mice. Renal lesions of KK/Ta mice closely resemble those in human early diabetic nephropathy. Thus, the KK/Ta mouse may serve as a suitable model for the study of type 2 diabetes and early diabetic nephropathy in humans. We reviewed genetic susceptibility using genome-wide linkage analysis and differential display polymerase chain reaction (DD-PCR) or Northern blot analysis, and treatment of diabetic nephropathy using angiotensin type 1 (AT1) receptor blockers (ARB) or thiazolidinediones (TZDs) in KK/Ta mice.
Insights
The KK/Ta mouse model offers a valuable tool for studying diabetic nephropathy, closely mimicking human early-stage kidney disease. This model aids research into genetic factors and treatments for type 2 diabetes complications.
Area of Science:
- Nephrology
- Endocrinology
- Genetics
Background:
- Diabetic nephropathy is a leading cause of end-stage renal failure in diabetes patients.
- Disease progression is influenced by genetic, hyperglycemic, hypertensive, and dyslipidemic factors.
- Human diabetic nephropathy is complex, necessitating reliable animal models for mechanistic studies.
Purpose of the Study:
- To evaluate the KK/Ta mouse as a model for human type 2 diabetes and early diabetic nephropathy.
- To review genetic susceptibility factors using genome-wide linkage analysis and DD-PCR/Northern blot.
- To examine the efficacy of treatments like ARBs and TZDs in this model.
Main Methods:
- Comparative analysis of KK/Ta mice and BALB/c mice for metabolic and renal parameters.
- Genome-wide linkage analysis to identify genetic susceptibility loci.
- Differential display polymerase chain reaction (DD-PCR) and Northern blot analysis for gene expression.
- Administration of angiotensin type 1 (AT1) receptor blockers (ARBs) and thiazolidinediones (TZDs) to assess treatment effects.
Main Results:
- KK/Ta mice exhibit distinct genetic backgrounds, body weight, blood glucose, impaired glucose tolerance, albuminuria, and triglyceride levels compared to BALB/c mice.
- Renal lesions in KK/Ta mice closely resemble early human diabetic nephropathy.
- The KK/Ta model is suitable for investigating genetic factors and therapeutic interventions in diabetic nephropathy.
Conclusions:
- The KK/Ta mouse is a relevant model for studying type 2 diabetes and early diabetic nephropathy.
- This model facilitates the investigation of genetic susceptibility and the evaluation of potential treatments for diabetic kidney disease.
Related Concept Videos
Type II Diabetes II: Pathophysiology
Diabetic Nephropathy
Type II Diabetes I: Introduction
Type I Diabetes II: Pathophysiology
Diabetes Mellitus: Type 2 and Gestational
Diabetic Ketoacidosis ll: Pathophysiology
